BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2014
View Archived Issues
Merrimack Pharmaceuticals begins phase II trial of MM-302 in HER2-positive breast cancer
Read More
NIPER reports novel PON 1 enzymes
Read More
Forma Therapeutics and Paradigm enter into molecular profiling collaboration
Read More
Characterization of potential disease-causing mutations in tRNA genes
Read More
AstraZeneca reports topline results from pivotal studies of lesinurad for gout
Read More
Seattle Genetics begins phase I study of SGN-CD70A
Read More
Novogen receives funding to begin studies in muscular dystrophy
Read More
Advanced Proteome Therapeutics updates progress of cancer program
Read More
Pfizer presents DGAT2 inhibitors with activity in preclinical models of metabolic disease
Read More
23andMe and Pfizer collaborate to investigate genetics of inflammatory bowel disease
Read More
Flex Pharma reports data for proprietary product for preventing muscle cramps
Read More
Novel small-molecule GK-GKRP inhibitors with the ability to lower blood glucose levels in vivo
Read More
First-in-class APOBEC3 enzyme inhibitors identified as potential oncolytic candidates
Read More
Merck & Co. reports glucokinase activators as diabetes treatment candidates
Read More
Novel ACC-beta inhibitors described by Boehringer Ingelheim
Read More
New vaccines for Francisella tularensis infection
Read More
Researchers at Janssen disclose novel agents for RSV infection
Read More
Roche synthesizes new LMP7 inhibitors
Read More
FDA approves Belsomra for insomnia
Read More
Insys Therapeutics submits NDA for new oral formulation of dronabinol
Read More
RedHill Biopharma gains option for RP-101 from RESprotect
Read More
Lithera changes name to Neothetics
Read More
Phase II trial to test safety and efficacy of fexinidazole in Chagas disease
Read More
Sirona subsidiary receives funding for anti-aging project
Read More
Rigel's R-348 misses endpoints in keratoconjunctivitis sicca trial
Read More
Medicure reports data from phase II trial of Tardoxal in tardive dyskinesia
Read More
Allergan acquires lidocaine for interstitial cystitis/bladder pain syndrome
Read More